Cost-effectiveness of stress echocardiography and nuclear perfusion imaging

Progress in Cardiovascular Diseases

Volumn 43, Issue 3, 2000, Pages 197-214

  Chee, Nicholas K ^a   Bateman, Timothy M ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HUMAN; MYOCARDIAL HIBERNATION; OUTCOMES RESEARCH; PREOPERATIVE EVALUATION; RISK ASSESSMENT; SCINTIANGIOCARDIOGRAPHY; STRESS ECHOCARDIOGRAPHY; SURGICAL RISK;

EID: 0034528001     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.19312     Document Type: Article

References (101)

1. Annual summary of births, marriages, divorces and deaths, United States 1994
2. Clinical economics. A guide to the economic analysis of clinical practices
3. Effectiveness in health care: An initiative to improve medical practice
4. A clinician's guide to cost-effectiveness analysis
5. Cost-effectiveness and cost-benefit analysis in the medical literature. Are the methods being used correctly?
6. Economic assessments of medical practices and technologies
7. The role of cost-effectiveness analysis in health and medicine
8. A survey of standards and guidelines for cost-effectiveness analysis in health care
9. The effectiveness of cost-effectiveness analysis in containing costs
10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
11. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction
12. Cost-effectiveness perspectives in coronary heart disease
13. Cost-effective strategies in cardiology
14. Cost-effective strategies in cardiology
15. Cost-effectiveness analysis in heart disease, part II: Preventive therapies
16. The cost-effectiveness of airbags by seating position
17. The cost effectiveness of three programs to increase the use of bicycle helmets among children
18. Recommendation of the panel on cost-effectiveness in health and medicine
19. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology. Part I
20. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology. Part II
21. Coronary angiography rates following stress SPECT scintigraphy
22. Impact of exercise single photon emission computed tomographic thallium imaging on patient management and outcome
23. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification
24. Cost-effectiveness of diagnostic strategies for patients with chest pain
25. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance
26. Markov models in medical decision making: A practical guide
27. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS)
28. Coronary arteriography 1984-1987: A report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications
29. Coronary arteriography 1984-1987: A report of the Registry of the Society for Cardiac Angiography and Interventions. II. An analysis of 218 deaths related to coronary arteriography
30. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
31. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialist Collaboration
32. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates
33. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)
34. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial
35. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI)
36. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
37. Bypass surgery for chronic stable angina: Predictors of survival benefit and strategy for patient selection
38. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease
39. Long-term survival and risk stratification in patients with angina at rest undergoing medical treatment
40. Coronary Artery Surgery Study (CASS): Comparability of 10-year survival in randomized and randomizable patients
41. Long-term survival in medically treated patients with ischemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1)
42. Determinants of survival 10 to 14 years after coronary bypass: Analysis of preoperative variables of 1,448 patients
43. Long-term survival of more than 2,000 patients after coronary artery bypass grafting
44. Choosing the appropriate stress modality
45. Long term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients
46. Prognostic value of pharmacologic stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
47. The declining specificity of exercise radionuclide ventriculography
48. Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary arteriography
49. Sex and test verification bias: Impact on the diagnostic value of exercise echocardiography
50. Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease?
51. Cost-effectiveness of alternative test strategies of the diagnosis of coronary artery disease
52. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease
53. Impact of stress single-photon emission computed tomography perfusion imaging on downstream resource utilization
54. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precatheterization ischemia
55. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease
56. Use of exercise echo for prognostic evaluation of patients with known or suspected coronary artery disease
57. Prognostic usefulness of positive or negative stress echocardiography for predicting coronary events in ensuing twelve months
58. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease
59. Exercise echo predicts cardiac events independent of exercise findings at small incremental cost - 4 year follow-up in 500 patients
60. Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease
61. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina predicting late cardiac events in patients with suspected coronary artery disease
62. Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators: Outcomes in patient with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
63. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
64. Evaluation of the post-infarct patient
65. Resource utilization in treatment of acute myocardial infarction: Staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators
66. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
67. Prediction of cardiac events after uncomplicated myocardial infarction: A prospective study comparing predischarge exercise thallium- 201 scintigraphy and coronary angiography
68. The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
69. Risk stratification after myocardial infarction
70. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction. A large-scale, multicenter trial
71. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: Feasibility, tolerability, safety and in-hospital prognostic value
72. Early dipyridamole technetium 99m sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and post discharge cardiac events. Comparison with submaximal exercise imaging
73. Guidelines for the clinical use of cardiac radionuclide imaging: Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology
74. ACC/AHA guidelines for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
75. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting
76. ACC/AHA Task Force Report. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American hart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
77. Striking hospital to hospital variation in pre-operative cardiac work-up for patients referred for major non-cardiac surgery
78. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery
79. Coronary artery revascularization before abdominal aortic aneurysm surgery: A decision analytic approach
80. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical patients
81. Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery
82. Perioperative cardiac evaluation for non-cardiac surgery noninvasive cardiac testing
83. Prognostic utility of myocardial viability assessment
84. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
85. Value of metabolic imaging with positron emission tomography for evaluation prognosis in patients with coronary artery disease and left ventricular dysfunction
86. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: Relative efficacy of medical therapy and revascularization
87. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
88. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization
89. Cost effectiveness of positron emission tomography (PET) in the management of ischemic cardiomyopathy patients who are referred for cardiac transplantation
90. Role of positron emission tomographic assessment of myocardial viability in the management of patients who are referred for cardiac transplantation
91. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
92. Identification of viable myocardium
93. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
94. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
95. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
96. Value of gating of technetium-99m-sestamibi SPECT
97. Using gated technetium-99m-sestamibi SPECT to characterize fixed defects as infarct or artifact
98. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization
99. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy